BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9742140)

  • 1. Targeting of IgMkappa antibodies to oligodendrocytes promotes CNS remyelination.
    Asakura K; Miller DJ; Pease LR; Rodriguez M
    J Neurosci; 1998 Oct; 18(19):7700-8. PubMed ID: 9742140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal remyelination-promoting natural autoantibody SCH 94.03: pharmacokinetics and in vivo targets within demyelinated spinal cord in a mouse model of multiple sclerosis.
    Hunter SF; Miller DJ; Rodriguez M
    J Neurol Sci; 1997 Sep; 150(2):103-13. PubMed ID: 9268236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monoclonal autoantibody which promotes central nervous system remyelination is highly polyreactive to multiple known and novel antigens.
    Asakura K; Pogulis RJ; Pease LR; Rodriguez M
    J Neuroimmunol; 1996 Mar; 65(1):11-9. PubMed ID: 8642059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis.
    Miller DJ; Sanborn KS; Katzmann JA; Rodriguez M
    J Neurosci; 1994 Oct; 14(10):6230-8. PubMed ID: 7931575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary structure of the antigen-binding domains of a human oligodendrocyte-reactive IgM monoclonal antibody derived from a patient with multiple sclerosis.
    Kirschning E; Jensen K; Dübel S; Rutter G; Hohenberg H; Will H
    J Neuroimmunol; 1999 Sep; 99(1):122-30. PubMed ID: 10496185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulins reactive with myelin basic protein promote CNS remyelination.
    Rodriguez M; Miller DJ; Lennon VA
    Neurology; 1996 Feb; 46(2):538-45. PubMed ID: 8614528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Method of identifying natural antibodies for remyelination.
    Warrington AE; Rodriguez M
    J Clin Immunol; 2010 May; 30 Suppl 1(0 1):S50-5. PubMed ID: 20387101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monoclonal natural autoantibody that promotes remyelination suppresses central nervous system inflammation and increases virus expression after Theiler's virus-induced demyelination.
    Miller DJ; Njenga MK; Murray PD; Leibowitz J; Rodriguez M
    Int Immunol; 1996 Jan; 8(1):131-41. PubMed ID: 8671597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis.
    Warrington AE; Asakura K; Bieber AJ; Ciric B; Van Keulen V; Kaveri SV; Kyle RA; Pease LR; Rodriguez M
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6820-5. PubMed ID: 10841576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune promotion of central nervous system remyelination.
    Rodriguez M; Miller DJ
    Prog Brain Res; 1994; 103():343-55. PubMed ID: 7886217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes.
    Asakura K; Miller DJ; Murray K; Bansal R; Pfeiffer SE; Rodriguez M
    J Neurosci Res; 1996 Feb; 43(3):273-281. PubMed ID: 8714516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique population of circulating autoantibodies promotes central nervous system remyelination.
    Asakura K; Rodriguez M
    Mult Scler; 1998 Jun; 4(3):217-21. PubMed ID: 9762677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
    Keirstead HS; Blakemore WF
    Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligodendrocyte-reactive O1, O4, and HNK-1 monoclonal antibodies are encoded by germline immunoglobulin genes.
    Asakura K; Miller DJ; Pogulis RJ; Pease LR; Rodriguez M
    Brain Res Mol Brain Res; 1995 Dec; 34(2):283-93. PubMed ID: 8750831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human monoclonal IgM antibody promotes CNS myelin repair independent of Fc function.
    Ciric B; Howe CL; Paz Soldan M; Warrington AE; Bieber AJ; Van Keulen V; Rodriguez M; Pease LR
    Brain Pathol; 2003 Oct; 13(4):608-16. PubMed ID: 14655764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination.
    Pavelko KD; van Engelen BG; Rodriguez M
    J Neurosci; 1998 Apr; 18(7):2498-505. PubMed ID: 9502810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-mediated CNS demyelination II. Focal spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma.
    Rosenbluth J; Schiff R; Liang WL; Dou W
    J Neurocytol; 2003 Mar; 32(3):265-76. PubMed ID: 14724389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remyelination-promoting human IgMs: developing a therapeutic reagent for demyelinating disease.
    Warrington AE; Rodriguez M
    Curr Top Microbiol Immunol; 2008; 318():213-39. PubMed ID: 18219820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monoclonal autoantibody that promotes central nervous system remyelination in a model of multiple sclerosis is a natural autoantibody encoded by germline immunoglobulin genes.
    Miller DJ; Rodriguez M
    J Immunol; 1995 Mar; 154(5):2460-9. PubMed ID: 7868912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The remyelinating potential and in vitro differentiation of MOG-expressing oligodendrocyte precursors isolated from the adult rat CNS.
    Crang AJ; Gilson JM; Li WW; Blakemore WF
    Eur J Neurosci; 2004 Sep; 20(6):1445-60. PubMed ID: 15355312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.